A Model-Informed Drug Development (MIDD) Approach for a Low Dose of Empagliflozin in Patients with Type 1 Diabetes
Pharmaceutics（2021）
关键词
Bayesian modeling,clinical trial simulations,SGLT2 inhibitor,supportive evidence,type 1 diabetes
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要